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Delivering Therapies with and to Stem Cells
The regenerative potential of stem cells extends beyond their ability to replace cellular components of damaged tissue. In some
cases, such as the example described in this issue by Uchida and colleagues, transplanted normal stem cells may provide protein
products that are missing in a diseased organ. In their research article, the authors transplant in vitro-expanded human NSCs to the
brains of mice that are deficient in the lysozymal enzyme PPT1, which model human Batten disease. The NSCs that engraft are suffi-
cient to extend the lifespan and minimize the neurodegenerative symptoms of the mutant recipient mice by protecting endogenous
neurons. Human Phase I clinical trials with banked human neural stem cells have been performed, and the approach appears suffi-
ciently safe to permit additional human testing. In some situations, direct genetic modification of the stem cells may be required.
Brivanlou and coauthors report an important step toward this goal in their resource article. The authors use an enhanced version
of the transposon-based ‘‘PiggyBac’’ system to reversibly deliver genes to human ESCs. Importantly, they show that the system
can be used to direct the engineered pluripotent cells to generate neural precursors, and these progeny remain stably differentiated
even after removal of the transgenic modification.Stem Cells Awake and Asleep
The paradigm of rarely cycling stem cells that give rise to transit amplifying progenitors is a defining aspect of
how most organ regeneration is thought to take place, especially in mammalian tissues. In the Drosophila
hindgut epithelium, however, very little constitutive tissue turnover occurs in the adult, according to
multiple lineage-tracing strategies employed by Fox and Spradling in this issue. In contrast, proliferation
and repair is observed after severe injury, raising the possibility that this invertebrate intestinal system may
offer additional important lessons to be transferred and tested in mammalian models. How quiescent stem
cells are both awakened and also returned to a state of dormant readiness remains a largely open question.
Also in this issue, Chazaud and colleagues investigate the impact of Ang1/Tie-2 signaling on the activation
status of normally quiescent satellite cells in skeletal muscle. Their results suggest that both intrinsic and
extrinsic signals participate to activate Tie-2 on satellite cells and promote the return of this population to
a state of quiescence after having been recruited into cycle in response to local injury. Consistent results implicating the importance
of this signaling cascade in maintaining self-renewing satellite cells were obtained both in vitro and in vivo and thus identify a candi-
date target for therapeutic intervention.A Time and a Place for Divisions
Tumbar and colleagues also employed lineage-tracing methods in their research article. In this case,
inducible fluorescent histone marks were used to track individual clones in murine hair follicle epithelium.
Their results indicate that regionally scattered, dividing clones either generate differentiated daughters or
expand the stem cell pool via self-renewing divisions, rather than the typically modeled pattern of
asymmetric divisions that generate one of each type of progeny. The inherent fate choices facing stem
cells when they divide may also make them prone oncogenic transformation, barring some mechanism
to overcome this susceptibility. For example, also in this issue, Gutkind and coauthors reveal that
although excessive b-catenin activation in the epidermis can lead to hyperproliferation and tumor growth,
hair-follicle stem cells appear to carry a ‘‘fail safe’’ mechanism that protects them from this outcome.
Specifically, overexpression of Wnt1 led to persistent activation of both b-catenin and the mTOR
pathway, resulting in eventual stem cell exhaustion and senescence rather than tumor growth. The poten-
tial utility of enlisting mTOR modifying agents for clinical benefit is discussed both in the Gutkind study and in the accompanying
preview article from Wood and Sabatini.The Call for Efficient iPSCs—Culture Matters?
Given that human iPSCs are considered an important new option for use as disease-specific drug screening tools, Colman and Dree-
sen outline important ‘‘points to consider’’ in designing an in vitro disease model with pluripotent cells—both human iPSCs and
ESCs—in their forum article. And yet, several remaining stumbling blocks face both clinical and research application of reprogram-
ming technologies, including the ongoing inefficiency of the process, especially using protocols that minimize or eliminate genetic
modifications. In this issue, Yamanaka and colleagues push the field another step closer by demonstrating that human and mouse
iPSCs can be generatedmore efficiently, both with integrating and nonintegrating approaches, simply by conducting the reprogram-
ming process in hypoxic culture conditions. As more labs move toward examining the impact of altered oxygen pressures on the
growth and fate of cells in culture, Wion and colleagues encourage stem cell scientists to take careful note of how those experiments
are conducted. In their letter, the authors highlight examples from the literature that demonstrate the power of hypoxic conditions and
their potential to influence stem cell function both in vitro and in vivo. They also call for more care in reporting how hypoxic conditions
are controlled in vitro in order to promote greater consistency and parity in across studies that compare hypoxic and normoxic condi-
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